ABOUT THE AUTHORS
Glenn D. Steele Jr., MD, PhD, serves as chairman of xG Health Solutions, an independently operated venture Geisinger launched to help healthcare organizations create value and improve quality, leveraging Geisinger intellectual property and expertise on issues such as population-health data analytics, care management, and health IT. He is the former president and chief executive officer of Geisinger Health System (2001–2015). Dr. Steele previously served as the dean of the Biological Sciences Division and the Pritzker School of Medicine and vice president for medical affairs at the University of Chicago, as well as the Richard T. Crane Professor in the Department of Surgery. Prior to that, he was the William V. McDermott Professor of Surgery at Harvard Medical School, president and chief executive officer of Deaconess Professional Practice Group, and chairman of the Department of Surgery at New England Deaconess Hospital. Dr. Steele is past chairman of the American Board of Surgery.
His investigations have focused on the cell biology of gastrointestinal cancer and precancer and most recently on innovations in healthcare delivery and financing. A prolific writer, he is the author or coauthor of nearly 500 scientific and professional articles.
Dr. Steele received his bachelor’s degree in history and literature from Harvard University and his medical degree from New York University School of Medicine. He completed his internship and residency in surgery at the University of Colorado, where he was also a fellow of the American Cancer Society. He earned his PhD in microbiology at Lund University in Sweden.
A member of the National Academy of Medicine, Dr. Steele serves on the Roundtable on Value and Science-Driven Healthcare, the Committee on the Governance and Financing of Graduate Medical Education, and the Vital Directions for Health and Health Care Steering Committee, and previously served on the Committee on Reviewing Evidence to Identify Highly Effective Clinical Services (HECS). A fellow of the American College of Surgeons, Dr. Steele is a member of the American Surgical Association, the American Society of Clinical Oncology, and past president of the Society of Surgical Oncology.
Dr. Steele serves on the following boards and national committees: Health Transformation Alliance (vice chair), City of Hope board of directors, Ingenious Med board of directors, PTC Therapeutics board of directors, Stratus Video board of directors, Synaptive Medical board of directors, Wellcare Health Plans Inc. board of directors, Healthcare Innovation Program (HIP) external advisory board (Emory University), and the Peterson Center on Healthcare advisory board. Dr. Steele formerly served on the following boards: Agency for Integrated Care (AIC) Singapore, Bucknell University board of trustees, Cepheid board of directors, Harvard Medical Faculty physicians board at Beth Israel Deaconess Medical Center, Premier, Inc. board (chairman 2011–2013), Temple University School of Medicine board of visitors, Weis Markets, Inc., Congressional Budget Office panel of health advisers, Commonwealth Fund’s Commission on a High Performance Health System, and American Hospital Association (AHA) board of trustees.
Dr. Steele is the recipient of several awards, NYU School of Medicine’s Solomon A. Berson Medical Alumni Achievement Award in Health Science, Medicine and the Arts (2016); AHA’s Justin Ford Kimball Innovators Award (2015); NCHL Gail L. Warden Healthcare Leadership Award (2014); HFMA Board of Directors’ Award (2011); AHA Health Research & Education Trust Award (2010); AHA’s Grassroots Champion Award (2007); and CEO IT Achievement Award (2006). He has been named consecutive times to the following lists: Modern Healthcare’s 50 Most Powerful Physician Executives in Healthcare, Modern Healthcare’s 100 Most Powerful People in Healthcare, and Becker’s Hospital Review’s 100 Nonprofit Hospital Health System CEOs to Know.
David T. Feinberg, MD, MBA, is president and chief executive officer of Geisinger, one of the nation’s largest health services organizations known for reinventing medical care. Geisinger is an integrated healthcare organization consisting of 13 hospital campuses, two research centers, a school of medicine, over 30,000 employees, 1,600 employed physicians, 420 residents and fellows, and a 583,000-member health plan, all serving and caring for more than 3 million residents in Pennsylvania and New Jersey.
A longtime champion of the patient experience, Dr. Feinberg has caught the industry’s attention by introducing Geisinger’s latest evolution of its renowned ProvenCare portfolio: ProvenExperience, which allows patients to request a refund based on the outcome of their patient experience.
Prior to joining Geisinger, Dr. Feinberg served as CEO of UCLA’s hospitals and associate vice chancellor of UCLA Health Sciences, as well as president of UCLA Health System.
Triple-board certified by the American Board of Psychiatry and Neurology in child, adolescent, and addiction psychiatry, Dr. Feinberg earned his undergraduate degree at the University of California, Berkeley, and graduated with distinction from the University of Health Sciences/Chicago Medical School. He earned a master of business administration from Pepperdine University.
Recognized among the 100 Most Influential People in Healthcare as well as in the top 3 of the 50 Most Influential Physician Executives and Leaders by Modern Healthcare, Dr. Feinberg’s numerous awards and recognitions include Alpha Omega Alpha Medical Honor Society; Medical Center CEO of the Year Healthcare Leadership Award; Leadership, Vision, and Commitment Honoree by the National Health Foundation; Distinguished Fellow of the American Psychiatric Association; and the Cancro Academic Leadership Award from the American Academy of Child and Adolescent Psychiatry. Dr. Feinberg is a well-known national speaker, especially on the subject of patient experience, and has published numerous articles.